FDA Adverse Event Malfunction Summary report: N

COULTER AC*T DIFF 2 ANALYZER

MDR report key: 3100852 · Received May 8, 2013

Report

Report Number
1061932-2013-00849
Event Type
Malfunction
Date Received
May 8, 2013
Date of Event
April 10, 2013
Report Date
April 10, 2013
Manufacturer
BECKMAN COULTER
Product Code
GKZ
PMA / PMN Number
K990352
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A BEC FIELD SERVICE ENGINEER (FSE) WAS DISPATCHED FOR THIS EVENT AND CONFIRMED THE LEAK. THE FSE REPLACED ALL ASSOCIATED BATH PINCH VALVE TUBINGS WHICH CORRECTED THE BATH OVERFLOW. TO RESOLVE THE HGB BLANK ERROR MESSAGES, THE FSE REPLACED THE HGB LAMP, SINCE IT WAS DAMAGED BY THE LEAK. PER LABELING, BECKMAN COULTER URGES ITS CUSTOMERS TO COMPLY WITH ALL NATIONAL HEALTH AND SAFETY STANDARDS SUCH AS THE USE OF BARRIER PROTECTION. THIS MAY INCLUDE, BUT IT IS NOT LIMITED TO, PROTECTIVE EYEWEAR, GLOVES, AND SUITABLE LABORATORY ATTIRE WHEN OPERATING OR MAINTAINING THIS OR ANY OTHER AUTOMATED LABORATORY ANALYZER. (B)(4).

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER (BEC) REPORTING 10 ML OF DILUENT LEAKING FROM THE BATHS OF THE COULTER AC*T DIFF 2 HEMATOLOGY ANALYZER WHILE COMPLETING A STARTUP. THE LEAK WAS NOT CONTAINED WITHIN THE INSTRUMENT. A HEMOGLOBIN (HGB) BLANK VOLTAGE ERROR WAS RECOVERED. THE CUSTOMER WAS WEARING PERSONAL PROTECTIVE EQUIPMENT (PPE) CONSISTING OF GLOVES AND EYE PROTECTION AT THE TIME OF OCCURRENCE. THE MATERIAL SAFETY DATA SHEET (MSDS) WAS REVIEWED. THE LABORATORY'S EXPOSURE CONTROL/RISK MANAGEMENT PLANS ARE IN PLACE. THERE WAS NO BIOHAZARD EXPOSURE TO MUCOUS MEMBRANES OR OPEN WOUNDS. MEDICAL ATTENTION WAS NOT SOUGHT. NO ERRONEOUS RESULTS WERE GENERATED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
200725 COULTER AC*T DIFF 2 ANALYZER COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER ACT DIFF 2 NA

Patients

Seq Age Sex Outcome Treatment
1